Product Information
FLUPHENAZINE 1 MG TABLET is a generic product labeled by AvPAK, priced at $0.2128 per EA under NDC 50268036615. Its NADAC has been published 205 times since Nov 2, 2022.
FDA first approved this application on Jan 7, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
AvPAKNDC
50268036615
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUPHENAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214534FDA Approved
1/7/2021
TE Code
AB
On Market Since
7/6/2022
Pharmacological Classes
Price Statistics
The NADAC for FLUPHENAZINE 1 MG TABLET has been published 205 times since Nov 2, 2022, and over the history we have for it it has declined 68.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2128 per EA |
|---|---|
| All-time high | $0.9239 (Apr 12, 2023) |
| All-time low | $0.1619 (Jul 22, 2026) |
| 52-week high | $0.3532 |
| 52-week low | $0.1619 |
| Median price | $0.3086 |
| Average price | $0.3513 |
| Largest weekly change | -56.4% (Apr 19, 2023) |
| Weeks tracked | 205 |
| Tracking since | Nov 2, 2022 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 54% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AvPAK manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluphenazine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUPHENAZINE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLUPHENAZINE 1 MG TABLET, manufactured by AvPAK, is $0.2128 per EA (NDC 50268036615), effective Sep 30, 2026.
How has the price of FLUPHENAZINE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLUPHENAZINE 1 MG TABLET has declined 68.2%. It has been tracked across 205 weekly CMS publications since Nov 2, 2022.
What are the highest and lowest recorded NADAC prices for FLUPHENAZINE 1 MG TABLET?
Since Nov 2, 2022, the NADAC for FLUPHENAZINE 1 MG TABLET has ranged from a low of $0.1619 (Jul 22, 2026) to a high of $0.9239 (Apr 12, 2023), with a median of $0.3086 per EA.
Are there cheaper alternatives to FLUPHENAZINE 1 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUPHENAZINE 1 MG TABLET, is $0.0970 per EA — about 54% below FLUPHENAZINE 1 MG TABLET.
Who manufactures FLUPHENAZINE 1 MG TABLET?
FLUPHENAZINE 1 MG TABLET (NDC 50268036615) is labeled by AvPAK, and CMS classifies it as a generic product.